Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Update

Health Catalyst, Inc. (NASDAQ:HCAT) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 2,940,000 shares, a growth of 24.1% from the February 28th total of 2,370,000 shares. Based on an average trading volume of 807,300 shares, the days-to-cover ratio is presently 3.6 days. Approximately 5.0% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on HCAT. Stephens reduced their price objective on shares of Health Catalyst from $7.00 to $5.00 and set an “equal weight” rating for the company in a report on Thursday, March 6th. KeyCorp upgraded Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 price target for the company in a research note on Wednesday, January 8th. Royal Bank of Canada lowered their price objective on Health Catalyst from $7.00 to $6.00 and set a “sector perform” rating for the company in a research note on Thursday, February 27th. Wells Fargo & Company cut their target price on Health Catalyst from $13.00 to $10.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 21st. Finally, Piper Sandler lowered their price target on Health Catalyst from $12.00 to $8.00 and set an “overweight” rating for the company in a research report on Tuesday, February 11th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $9.27.

Insider Activity

In related news, insider Linda Llewelyn sold 6,441 shares of the business’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $5.43, for a total value of $34,974.63. Following the completion of the sale, the insider now directly owns 85,819 shares of the company’s stock, valued at $465,997.17. The trade was a 6.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Daniel Lesueur sold 16,902 shares of the company’s stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $4.52, for a total value of $76,397.04. Following the transaction, the chief operating officer now directly owns 216,250 shares in the company, valued at $977,450. The trade was a 7.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 56,530 shares of company stock worth $299,572 in the last quarter. 2.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HCAT. Quantbot Technologies LP bought a new stake in shares of Health Catalyst in the 4th quarter worth approximately $29,000. Group One Trading LLC raised its stake in shares of Health Catalyst by 107.6% in the fourth quarter. Group One Trading LLC now owns 4,360 shares of the company’s stock valued at $31,000 after buying an additional 2,260 shares during the period. Quest Partners LLC purchased a new position in shares of Health Catalyst during the 3rd quarter valued at $34,000. Aquatic Capital Management LLC bought a new position in shares of Health Catalyst during the 4th quarter worth $63,000. Finally, Stoneridge Investment Partners LLC purchased a new stake in Health Catalyst in the 4th quarter worth about $77,000. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Health Catalyst Price Performance

Shares of NASDAQ:HCAT opened at $4.45 on Thursday. The company has a market capitalization of $312.44 million, a P/E ratio of -3.30 and a beta of 1.41. The company’s 50-day moving average is $4.96 and its 200 day moving average is $6.78. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41. Health Catalyst has a fifty-two week low of $3.76 and a fifty-two week high of $9.24.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.